BioLineRx (BLRX) EBITDA (2011 - 2025)
BioLineRx (BLRX) posted quarterly EBITDA of -$3.4 million for Q4 2025, up 23.5% year-over-year from -$2.7 million in Q4 2024, and down 53.42% quarter-over-quarter from -$2.2 million in Q3 2025.
BioLineRx (BLRX) EBITDA (2011 - 2025) Analysis & Trends
BioLineRx's EBITDA history runs 14 years deep, the most recent figure standing at -$3.4 million for Q4 2025.
- In Q4 2025, EBITDA rose 23.5% year-over-year to -$3.4 million; the TTM figure through Dec 2025 stood at -$10.3 million (up 49.59% YoY), while the FY2025 annual figure was -$10.3 million, up 49.59% from the prior year.
- EBITDA for Q4 2025 stood at -$3.4 million, down from -$2.2 million in the prior quarter.
- The five-year high for EBITDA was -$2.2 million in Q3 2025, with the low at -$18.6 million in Q4 2023.
- The 5-year median for EBITDA is -$6.1 million (2021), against an average of -$6.7 million.
- The sharpest annual moves came in 2023 and 2024: EBITDA plunged 121.08% in 2023, then soared 76.16% in 2024.
- BioLineRx's EBITDA stood at -$6.6 million in 2021, then declined by 27.28% to -$8.4 million in 2022, then slumped by 121.08% to -$18.6 million in 2023, then jumped by 76.16% to -$4.4 million in 2024, then rose by 23.5% to -$3.4 million in 2025.
- Business Quant data shows BLRX's EBITDA at -$3.4 million in Q4 2025, -$2.2 million in Q3 2025, and -$2.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 493.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 325.05 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2.33 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 133.12 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 231.44 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.55 Mn |
| 10 | BioLineRx | 7.21 Bn | 7.21 Bn | 154,000.00 | -3.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.39 Mn |
| Sep 30, 2025 | -2.21 Mn |
| Jun 30, 2025 | -2.30 Mn |
| Mar 31, 2025 | -2.39 Mn |
| Dec 31, 2024 | -4.43 Mn |
| Sep 30, 2024 | -5.39 Mn |
| Jun 30, 2024 | -5.77 Mn |
| Mar 31, 2024 | -4.82 Mn |
| Dec 31, 2023 | -18.57 Mn |
| Sep 30, 2023 | -12.36 Mn |
| Jun 30, 2023 | -9.92 Mn |
| Mar 31, 2023 | -8.86 Mn |
| Dec 31, 2022 | -8.40 Mn |
| Sep 30, 2022 | -7.08 Mn |
| Jun 30, 2022 | -7.60 Mn |
| Mar 31, 2022 | -6.08 Mn |
| Dec 31, 2021 | -6.60 Mn |
| Sep 30, 2021 | -6.22 Mn |
| Jun 30, 2021 | -6.51 Mn |
| Mar 31, 2021 | -5.45 Mn |